Experienced in Endometrial Stromal Sarcoma

Dr. Marvin J. Feldman

Hematology Oncology | Hematology | Oncology

227 St Paul Place, 4th Floor,

Baltimore, MD

Clinical Trials:Currently Recruiting for 1 Trial

Experienced in Endometrial Stromal Sarcoma

227 St Paul Place, 4th Floor,

Baltimore, MD

OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marvin Feldman is a Hematologist Oncology specialist and a Hematologist in Baltimore, Maryland. Dr. Feldman is rated as an Experienced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Anal Cancer, Laryngeal Cancer, Familial Colorectal Cancer, and Angiosarcoma.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology Oncology

Hematology

Oncology

Licenses

Internal Medicine in MD

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

CareFirst

Humana

HMO
INDEMNITY
POS
PPO

Locations

227 St Paul Place, 4th Floor, Baltimore, MD 21202

Call: 410-783-5858

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma

Enrollment Status: Recruiting

Publish Date: October 15, 2025

Intervention Type: Procedure, Biological

Study Drugs: Ipilimumab, Nivolumab, Sargramostim

Study Phase: Phase 2/Phase 3

Molecular Analysis for Therapy Choice (MATCH)

Enrollment Status: Active_not_recruiting

Publish Date: October 01, 2025

Intervention Type: Procedure, Drug, Other, Biological

Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib

Study Phase: Phase 2

A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer

Enrollment Status: Active_not_recruiting

Publish Date: September 15, 2025

Intervention Type: Other, Procedure, Drug

Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate

Study Phase: Phase 3

A Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Alpelisib (BYL719) in Combination With Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer With Either Phosphoinositide-3-kinase Catalytic Subunit Alpha (PIK3CA) Mutation or Phosphatase and Tensin Homolog Protein (PTEN) Loss Without PIK3CA Mutation

Enrollment Status: Active_not_recruiting

Publish Date: September 08, 2025

Intervention Type: Drug

Study Drugs: alpelisib, nab-paclitaxel

Study Phase: Phase 3

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation

Enrollment Status: Active_not_recruiting

Publish Date: July 30, 2025

Intervention Type: Other, Drug

Study Drugs: Temozolomide, Veliparib

Study Phase: Phase 2/Phase 3

Randomized Phase II Study of Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced G3 Non-small Cell Gastroenteropancreatic Neuroendocrine Carcinomas

Enrollment Status: Active_not_recruiting

Publish Date: March 18, 2025

Intervention Type: Drug, Other

Study Drugs: Capecitabine, Carboplatin, Cisplatin, Etoposide, Temozolomide

Study Phase: Phase 2

A Phase III Randomized Double-blind, Placebo Controlled Study of Alpelisib in Combination With Fulvestrant for Men and Postmenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment

Enrollment Status: Completed

Publish Date: February 13, 2025

Intervention Type: Drug

Study Drugs: Fulvestrant, Alpelisib

Study Phase: Phase 3

A Phase I/Randomized Phase II Study of MLN0128 (TAK-228) VS. Pazopanib in Patients With Locally Advanced/Unresectable and/or Metastatic Sarcoma

Enrollment Status: Terminated

Publish Date: August 23, 2022

Intervention Type: Drug

Study Drugs: Pazopanib, Pazopanib Hydrochloride, Sapanisertib

Study Phase: Phase 1/Phase 2

View 7 Less Clinical Trials

4 Total Publications

Marital Status and Overall Survival in Patients with Resectable Pancreatic Cancer: Results of an Ancillary Analysis of NRG Oncology/RTOG 9704.

Journal: The oncologist

Published: July 24, 2019

View All 4 Publications

Similar Doctors

Distinguished in Endometrial Stromal Sarcoma

Dr. Teresa P. Diaz-Montes

Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Distinguished in Endometrial Stromal Sarcoma

Dr. Teresa P. Diaz-Montes

Gynecologic Oncology | Oncology | Obstetrics and Gynecology

St Paul Place Specialists Inc

301 Saint Paul St,

Baltimore, MD

(0.1 miles away)

Languages Spoken:

English, Spanish

See accepted insurances

Accepting New Patients

Teresa Diaz-Montes is a Gynecologic Oncologist and an Oncologist in Baltimore, Maryland. Dr. Diaz-Montes is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. Her top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Vulvar Cancer, Hysterectomy, and Ureteroscopy. Dr. Diaz-Montes is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma

Dr. Dwight D. Im

Gynecologic Oncology | Oncology

Distinguished in Endometrial Stromal Sarcoma

Dr. Dwight D. Im

Gynecologic Oncology | Oncology

St Paul Place Specialists Inc

7602 Belair Rd,

Baltimore, MD

(7.2 miles away)

410-663-8100

Languages Spoken:

English, Korean

See accepted insurances

Accepting New Patients

Dwight Im is a Gynecologic Oncologist and an Oncologist in Baltimore, Maryland. Dr. Im is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Rectocele, Endometrial Cancer, Endometrial Stromal Sarcoma, Hysterectomy, and Oophorectomy. Dr. Im is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma

Dr. Hyung S. Ryu

Gynecologic Oncology | Oncology | Obstetrics and Gynecology

Distinguished in Endometrial Stromal Sarcoma

Dr. Hyung S. Ryu

Gynecologic Oncology | Oncology | Obstetrics and Gynecology

St Paul Place Specialists Inc

227 Saint Paul St,

Baltimore, MD

(0.1 miles away)

410-332-9000

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Hyung Ryu is a Gynecologic Oncologist and an Oncologist in Baltimore, Maryland. Dr. Ryu is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, and Hernia Surgery. Dr. Ryu is currently accepting new patients.

VIEW MORE ENDOMETRIAL STROMAL SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Feldman's expertise for a condition

ConditionClose